Nuclear Tkt promotes ischemic heart failure via the cleaved Parp1/Aif axis

Zhiyan Wang1,2, Zeping Qiu1,2, Sha Hua3

  • 1Department of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200023, People's Republic of China.

Insights

Transketolase (Tkt) elevation worsens heart attack outcomes by promoting heart cell death. Inhibiting Tkt in heart cells protects against cardiac dysfunction following ischemic injury.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Enzymology

Background:

  • Transketolase (Tkt) is known to affect cancer cell survival and genome stability.
  • Its role in cardiac ischemic injury, such as myocardial infarction (MI), is not well understood.

Purpose of the Study:

  • To investigate the function of Transketolase (Tkt) in the context of myocardial ischemic injury.
  • To elucidate the molecular mechanisms by which Tkt influences cardiomyocyte apoptosis and cardiac function.

Main Methods:

  • Label-free proteomics to identify protein changes in murine hearts post-MI.
  • Lentivirus-mediated Tkt knockdown and overexpression in cardiomyocytes.
  • Generation of inducible conditional cardiomyocyte Tkt-knockout mice.
  • Luciferase assay and chromatin immunoprecipitation to determine Tkt's transcriptional regulation.
  • Analysis of Tkt's interaction with Poly(ADP-ribose) polymerase 1 (Parp1) and Apoptosis Inducible Factor (Aif).

Main Results:

  • Proteomics revealed significantly elevated Tkt levels in hearts after MI.
  • Tkt knockdown improved cardiac function and reduced cardiomyocyte apoptosis post-MI, while overexpression worsened outcomes.
  • Cardiomyocyte-specific Tkt knockout mice exhibited reduced heart failure.
  • Tkt was identified as a direct target of Krüppel-like factor 5 (Klf5).
  • Nuclear Tkt directly binds to Parp1, facilitates its cleavage, and activates Aif, promoting apoptosis.

Conclusions:

  • Elevated Transketolase (Tkt) plays a detrimental, non-metabolic role in ischemic heart failure.
  • Nuclear Tkt promotes cardiomyocyte apoptosis through the Parp1/Aif pathway, contributing to cardiac dysfunction.
  • Targeting Tkt may offer a therapeutic strategy for myocardial ischemic injury.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.4K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.9K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K